Scope
- This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
- The report covers the Continuous Monitoring theme.
Reasons to Buy
- The publisher's thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
- Develop and design your corporate strategies through an in-house expert analysis of Continuous Monitoring by understanding the primary ways in which this theme is impacting the medical devices industry.
- Stay up to date on the industry's major players and where they sit in the value chain.
- Identify emerging industry trends to gain a competitive advantage.
Table of Contents
Executive Summary- Players
- Technology Briefing
- Trends
- Technology trends
- Macroeconomic trends
- Regulatory trends
- Industry Analysis
- Market size and growth forecasts
- COVID-19 helped continuous glucose monitors take off
- Mergers and acquisitions
- Venture financing
- Hiring trends
- Social media trends
- Timeline
- Value Chain
- Foundation
- External vs. implantable continuous monitoring
- Tools
- User interface
- Experience
- Companies
- Public companies
- Private companies
- Glossary
- Further Reading
- Thematic Research Methodology
- About the Publisher
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apple
- Alphabet
- Medtronic
- Garmin
- Microsoft
- Under Armour
- Xiaomi
- DexCom
- 3M
- AliveCor
- F. Hoffmann-La Roche
- GE Healthcare
- Philips
- Verily Life Sciences
- Biotronik
- Boston Scientific
- Abbott
- LivaNova
- Inspire Medical Systems